Collectively, these findings elucidate that the FLG-AS1/miR-23a-3p/HOXD10 signaling pathway impedes the migratory and invasive capabilities of ESCC cells by modulating their glycometabolic processes. This evidence concerns the gene FLG and esophageal squamous cell carcinoma.